Virtus ETF Advisers’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-290
| Closed | -$11.8K | – | 436 |
|
|
2023
Q3 | $11.8K | Sell |
290
-29
| -9% | -$1.18K | 0.01% | 433 |
|
|
2023
Q2 | $34K | Sell |
319
-12
| -4% | -$1.28K | 0.02% | 434 |
|
|
2023
Q1 | $98.9K | Sell |
331
-127
| -28% | -$37.9K | 0.05% | 342 |
|
|
2022
Q4 | $158K | Sell |
458
-252
| -35% | -$86.7K | 0.08% | 331 |
|
|
2022
Q3 | $134K | Buy |
710
+5
| +0.7% | +$944 | 0.05% | 370 |
|
|
2022
Q2 | $149K | Buy |
705
+223
| +46% | +$47.1K | 0.06% | 319 |
|
|
2022
Q1 | $161K | Sell |
482
-28
| -5% | -$9.35K | 0.07% | 216 |
|
|
2021
Q4 | $166K | Buy |
510
+163
| +47% | +$53.1K | 0.06% | 304 |
|
|
2021
Q3 | $168K | Sell |
347
-17
| -5% | -$8.23K | 0.07% | 315 |
|
|
2021
Q2 | $169K | Sell |
364
-41
| -10% | -$19K | 0.07% | 388 |
|
|
2021
Q1 | $280K | Buy |
405
+7
| +2% | +$4.84K | 0.12% | 255 |
|
|
2020
Q4 | $294K | Sell |
398
-7
| -2% | -$5.17K | 0.12% | 223 |
|
|
2020
Q3 | $281K | Sell |
405
-56
| -12% | -$38.9K | 0.15% | 237 |
|
|
2020
Q2 | $391K | Buy |
+461
| New | +$391K | 0.19% | 204 |
|